05:55:17 EDT Sat 04 May 2024
Enter Symbol
or Name
USA
CA



Cannvas Medtech Inc
Symbol MTEC
Shares Issued 37,954,461
Close 2018-11-06 C$ 0.37
Market Cap C$ 14,043,151
Recent Sedar Documents

ORIGINAL: Cannvas grants options to buy 630,000 shares

2018-11-06 19:09 ET - News Release

Received by email:

File: MTEC NR 2018 11 06 - Grant Options.docx

CANNVAS MEDTECH INC.
NEWS RELEASE
Cannvas MedTech Announces Option Grants
Toronto, Ontario / November 6, 2018 - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM), 
--->a leading business technology company in the cannabis space, announces that it has granted incentive stock options to 
--->purchase a total of 630,000 common shares at an exercise price of $0.37 per share for a period of five years to a dire
--->ctor and certain consultants in accordance with the provisions of its stock option plan.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric s
--->olutions that enable our partners to harness the power of data to truly understand their customers, industry, and key 
--->business drivers.
For additional information: www.cannvasmedtech.com 
Media Inquiries media@cannvasmedtech.com 
Investor Relations ir@cannvasmedtech.com  1-800-489-0116 
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accur
--->acy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that
---> describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management 
--->expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, 
--->by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties
---> facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and An
--->alysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.



© 2024 Canjex Publishing Ltd. All rights reserved.